Displaying 71 - 80 of 11412
Author year
Does molecular analysis increase the efficacy of bronchoalveolar lavage in the diagnosis and management of respiratory infections in hemato-oncological patients? Oren I, Hardak E, Zuckerman T, Geffen Y, Hoffman R, Yigla M, Avivi I. 2016
Eosinophilic Lung Diseases. Cottin V. 2016
Potential clinical and economic outcomes of active beta-D-glucan surveillance with preemptive therapy for invasive candidiasis at intensive care units: a decision model analysis. Pang YK, Ip M, You JH. 2017
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH. 2016
Clinical effectiveness of itraconazole as antifungal prophylaxis in AML patients undergoing intensive chemotherapy in the modern era. Keighley CL, Manii P, Larsen SR, van Hal S. 2017
Microbiological profile of corneal ulcer cases diagnosed in a tertiary care ophthalmological institute in Nepal. Suwal S, Bhandari D, Thapa P, Shrestha MK, Amatya J. 2016
Efficacy of in-house fluorescent stain for fungus. Kirani KR, Chandrika VS. 2017
Delphi-based study and analysis of key risk factors for invasive fungal infection in haematological patients. Vázquez L, Salavert M, Gayoso J, Lizasoaín M, Ruiz Camps I, Di Benedetto N; Study Group of Risk Factors for IFI using the Delphi Method. 2017
Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon. Alothman AF, Althaqafi AO, Matar MJ, Moghnieh R, Alenazi TH, Farahat FM, Corman S, Solem CT, Raghubir N, Macahilig C, Charbonneau C, Stephens JM. 2017
Usefulness of two Aspergillus PCR assays and Aspergillus galactomannan and β-D-glucan testing of bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis. Urabe N, Sakamoto S, Sano G, Suzuki J, Hebisawa A, Nakamura Y, Koyama K, Ishii Y, Tateda K, Homma S. 2017


Subscribe to Search